SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Company Response from Jaguar Health, Inc. (JAGX) (CIK 0001585608) (JAGX) — Jul 5, 2017

Jaguar Health, Inc. (JAGX) (CIK 0001585608)
Date: July 5, 2017 · CIK: 0001585608 · Accession: 0001104659-17-043473

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-217364

Date
July 5, 2017
Author
Assistant Director
Form
CORRESP
Company
Jaguar Health, Inc. (JAGX) (CIK 0001585608)

Letter

Re:

July 5, 2017

Via Email and EDGAR

Suzanne Hayes Assistant Director U.S. Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549

Jaguar Animal Health, Inc.

Registration Statement on Form S-4

File No. 333-217364

Ladies and Gentlemen:

Jaguar Animal Health, Inc., a Delaware corporation (the “Registrant”), hereby requests the above-referenced Registration Statement on Form S-4 (as amended, the “Registration Statement”) be declared effective by the Securities and Exchange Commission (the “Commission”) on July 6, 2017, at 4:00 p.m., Eastern Standard Time, or as soon thereafter as is practicable.

Please confirm effectiveness by advising our counsel, Donald C. Reinke of Reed Smith LLP, at (650) 352-0532.

Very truly yours,
Jaguar Animal Health, Inc.

Show Raw Text
CORRESP
1
filename1.htm

July 5, 2017

Via Email and EDGAR

Suzanne Hayes
 Assistant Director
 U.S. Securities and Exchange Commission
 100 F Street, N.E.
 Washington, D.C. 20549

Re:

Jaguar Animal Health, Inc.

Registration Statement on Form S-4

File No. 333-217364

Ladies and Gentlemen:

Jaguar Animal Health, Inc., a Delaware corporation (the “Registrant”), hereby requests the above-referenced Registration Statement on Form S-4 (as amended, the “Registration Statement”) be declared effective by the Securities and Exchange Commission (the “Commission”) on July 6, 2017, at 4:00 p.m., Eastern Standard Time, or as soon thereafter as is practicable.

Please confirm effectiveness by advising our counsel, Donald C. Reinke of Reed Smith LLP, at (650) 352-0532.

Very truly yours,

Jaguar Animal Health, Inc.

/s/ Lisa   A. Conte

Lisa A. Conte

Chief Executive Officer   and President

Jaguar Animal Health, Inc. · 201 Mission Street, Suite 2375 • San Francisco, CA 94105

Tel: +1 (415) 371-8300 · Fax: +1 (415) 371-8311 • www.jaguaranimalhealth.com